Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Rieder, F; Bettenworth, D; Ma, C; Parker, C E; Williamson, L A; Nelson, S A; van Assche, G; Di Sabatino, A; Bouhnik, Y; Stidham, R W; Dignass, A; Rogler, G; Taylor, S A; Stoker, J; Rimola, J; Baker, M E; Fletcher, J G; Panes, J; Sandborn, W J; Feagan, B G; Jairath, V (2018). An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Alimentary Pharmacology & Therapeutics, 48(3):347-357.

Rieder, F; Schleder, S; Wolf, A; Dirmeier, A; Strauch, U; Obermeier, F; Lopez, R; Spector, L; Fire, E; Yarden, J; Rogler, G; Dotan, N; Klebl, F (2010). Serum anti-glycan antibodies predict complicated Crohn's disease behavior: A cohort study. Inflammatory Bowel Diseases, 16(8):1367-1375.

Rieder, F; Sándor, P S (2010). Migräne und vaskuläres Risiko. Schweizer Zeitschrift für Psychiatrie & Neurologie, 10(1-2):13-15.

Rieder, F; Georgieva, M; Schirbel, A; Artinger, M; Zügner, A; Blank, M; Brenmoehl, J; Schölmerich, J; Rogler, G (2010). Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts. Inflammatory Bowel Diseases, 16(9):1505-1513.

Bataille, F; Rohrmeier, C; Bates, R; Weber, A; Rieder, F; Brenmoehl, J; Strauch, U; Farkas, S; Fürst, Alois; Hofstädter, F; Schölmerich, J; Herfarth, H; Rogler, G (2008). Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflammatory Bowel Diseases, 14(11):1514-1527.

This list was generated on Fri Jul 19 01:39:27 2019 CEST.